Tutorials › Pattern-Mixture and Selection Models › Hypothetical Estimands

The Estimand Framework and Intercurrent Events · Tutorial 379 of 499

Hypothetical Estimands

Learn to specify the counterfactual clinical scenario behind a hypothetical estimand and interpret the treatment contrast it targets.

Intermediate 12 min read

What You'll Learn

  • Define potential outcomes under a specified scenario that prevents an intercurrent event.
  • State the clinical meaning of the scenario rather than leaving “if the event did not occur” vague.
  • Distinguish a hypothetical estimand from a comparison among participants who happened not to experience the event.
  • Calculate and interpret a treatment contrast using hypothetical outcome means.
  • Identify assumptions and diagnostics that matter when estimating outcomes under the hypothetical scenario.

What Does “If the Event Had Not Occurred” Mean?

A participant may start rescue medication, discontinue assigned treatment, or experience another event that changes how a trial outcome is observed or interpreted. A hypothetical estimand asks a counterfactual clinical question: what would the outcome, and the treatment contrast, have been under a specified scenario in which that event did not occur? The phrase “did not occur” is not yet a complete clinical question. It must be made clear what is imagined to happen instead, and what treatment and outcome are being considered.

For example, asking what symptoms would have been at week 24 if rescue medication had not been started is different from asking what symptoms would have been if the participant had continued assigned treatment without rescue medication. The first leaves treatment after rescue unspecified; the second describes more of the scenario but may or may not be clinically plausible. A useful hypothetical estimand makes the imagined scenario precise enough that clinicians can interpret the result.

Definition: A hypothetical estimand is a population-level quantity defined for outcomes under a specified hypothetical scenario in which an intercurrent event does not occur. For treatment arms \(a=0,1\), let \(Y^{a,g}\) denote the outcome that would occur under assigned treatment \(a\) and the specified scenario \(g\). A mean-difference estimand can be written as \(\theta_g=E[Y^{1,g}]-E[Y^{0,g}]\). The population, outcome, time point, treatment conditions, and scenario \(g\) together determine the clinical meaning of this contrast.

Here \(Y^{a,g}\) is a counterfactual outcome: it is the outcome for a participant under treatment \(a\) in the stated scenario, whether or not that participant actually experienced the event. It is not automatically the outcome observed among participants who happened not to experience the event. The scenario could, for example, specify that rescue medication is not initiated while assigned treatment continues according to a defined regimen. It should say what happens to treatment, follow-up, and other relevant care as far as needed to make the outcome interpretable.

Specify the Clinical Scenario Before the Contrast

The five attributes of an estimand provide a useful structure: population, treatment conditions, variable (outcome), handling of intercurrent events, and population-level summary. For a hypothetical estimand, the event-handling attribute must state the scenario that replaces the event. The other attributes remain necessary. A statement such as “the treatment effect if there were no rescue” is incomplete if it does not say which population, which outcome and time point, and which treatment contrast are intended.

A clinically meaningful scenario should answer questions such as these:

  • Which event is being prevented or set aside?
  • What treatment and care continue instead, and does the imagined scenario apply in both randomized arms?
  • What outcome is defined at the target time under that scenario?
  • Is the scenario plausible enough to inform the clinical decision at hand?

The answer need not claim that the imagined course is routinely achievable. It does need to be clear about what is being imagined. If avoiding the event would require withholding necessary treatment, for instance, the estimand may be mathematically expressible but clinically difficult to interpret or ethically unhelpful. A hypothetical estimand concerns the stated scenario; it does not establish that preventing the event would be safe, feasible, or a recommended clinical action.

Worked Example: Rescue Medication and a Week-12 Symptom Score

Consider a hypothetical randomized trial comparing a new treatment (\(A=1\)) with control (\(A=0\)). The outcome is a symptom score at week 12, with lower scores indicating fewer symptoms. Starting rescue medication before week 12 is an intercurrent event. The proposed scenario \(g\) is: no participant starts rescue medication before week 12, and each participant otherwise follows the assigned treatment and specified background care. Suppose a prespecified analysis estimates mean week-12 scores under this scenario as 18.2 for the new treatment and 22.7 for control.

Estimand. The mean treatment difference in week-12 symptom score for the trial population under scenario \(g\) is \( \theta_g=E[Y^{1,g}]-E[Y^{0,g}] \). The outcome is a score in points, so the contrast is also in points.

Calculation. \( \widehat{\theta}_g=18.2-22.7=-4.5 \) points.

Interpretation. Under the specified no-rescue scenario, the estimated mean score is 4.5 points lower for assignment to the new treatment than for assignment to control. This is a contrast of outcomes under the scenario; it is not a claim that each participant would improve by 4.5 points, nor that the observed participants who did not use rescue medication had a 4.5-point treatment difference.

The scenario also needs clinical review. “No rescue medication” does not, by itself, say whether participants continue assigned treatment or what other care is available. The calculation is interpretable only because the example specified those parts of the scenario; a real protocol and estimand should do so explicitly.

Why the No-Event Subgroup Is Not the Hypothetical Population

It is tempting to compare outcomes only among participants who did not experience the event. That comparison answers a different question. Event occurrence can be related to prognosis, treatment response, or other participant characteristics. In a randomized trial, randomization balances treatment groups at baseline, but it does not guarantee that the subsets who remain event-free are comparable: membership in those subsets is determined after randomization and may differ between arms.

In notation, an observed no-event comparison might compare \(E[Y\mid A=1,E=0]\) with \(E[Y\mid A=0,E=0]\), where \(E\) records whether the event occurred. A hypothetical contrast instead compares \(E[Y^{1,g}]\) with \(E[Y^{0,g}]\). The former conditions on observed event status; the latter refers to outcomes under a defined scenario. These quantities are generally not equal.

Worked Example: A No-Event Comparison Can Mislead

Suppose 100 participants are randomized to each arm in a hypothetical trial. In the new-treatment arm, 30 start rescue medication and 70 do not; in the control arm, 10 start rescue and 90 do not. Among those observed not to start rescue, the mean scores are 16 points in the new-treatment arm and 21 points in control. A model estimating outcomes under the specified no-rescue scenario gives arm means of 19 points and 22 points, respectively.

Observed no-event comparison. Its treatment difference is \(16-21=-5\) points.

Hypothetical contrast. Under the specified scenario, its estimated treatment difference is \(19-22=-3\) points.

The two results differ by 2 points. Neither arithmetic result is inconsistent: they summarize different quantities. The no-event comparison uses selected observed subsets, which make up 70% of the new-treatment arm and 90% of the control arm. The hypothetical contrast concerns the full target population under the scenario, and requires an analysis that estimates outcomes for participants whose actual course included rescue. The numbers do not establish which analysis is appropriate; that depends on the clinical question and whether the scenario and its estimation assumptions are defensible.

From a Counterfactual Question to an Estimable Quantity

The definition of the estimand does not, on its own, tell us how to estimate it from trial data. For participants who experience the event, the outcome under the hypothetical no-event scenario is not directly observed. Estimation therefore requires assumptions and an analysis model or other method that connects observed data to the counterfactual outcomes. This is a point where the clinical scenario and statistical assumptions must be considered together: a model cannot rescue a scenario that has no coherent clinical interpretation.

A basic justification for the mean-difference form is linearity of expectation. For each participant, imagine the two scenario-specific potential outcomes \(Y^{1,g}\) and \(Y^{0,g}\). The population average of their individual differences satisfies

$$ E[Y^{1,g}-Y^{0,g}] = E[Y^{1,g}]-E[Y^{0,g}] = \theta_g. $$

This identity defines a population treatment contrast; it does not say that both potential outcomes are observed for any participant. In a randomized trial, randomization supports comparison of assigned treatment groups for outcomes defined by the actual trial course. It does not by itself reveal the unobserved outcomes under \(g\) for participants whose event occurred. Additional assumptions are needed for that step.

Among the assumptions to consider are:

  • Well-defined scenario and consistency: the scenario and treatment conditions are sufficiently specified, and observed outcomes agree with the corresponding potential outcome when a participant’s actual course matches those conditions.
  • Randomization and appropriate analysis: treatment assignment follows the trial’s randomization scheme, and the analysis respects the assignment and target population used to define the estimand.
  • Support for the scenario: the observed data contain enough relevant information to estimate outcomes under the scenario. If particular kinds of participants almost always experience the event, their hypothetical outcomes may depend heavily on extrapolation.
  • Correct assumptions for unobserved outcomes: the model or other estimation method must adequately represent the relationship between observed information and outcomes under \(g\). Randomization alone does not ensure this.

When the scenario involves decisions over time, such as continuing or changing treatment as symptoms evolve, additional assumptions about the time-varying history and treatment decisions may be required. The details depend on the scenario and analysis. The central distinction remains: the estimand states the clinical quantity; the estimation method and its assumptions determine how the available data are used to learn about it.

Worked Example: Clarifying an Ambiguous Discontinuation Question

A trial team proposes: “Estimate the week-24 score if participants had not discontinued treatment.” That sentence names an event and time point, but not a complete scenario. Consider two possible completions:

Scenario 1: Participants who would otherwise discontinue remain on their assigned treatment through week 24, with follow-up and background care as specified in the protocol. The estimand is the mean week-24 score contrast between assigned treatments under this continuation scenario.

Scenario 2: Discontinuation is prevented, but the treatment participants receive after the time they would have discontinued is unspecified. In this case, the week-24 counterfactual outcome is not clearly defined: different post-event treatment courses could produce different scores.

Only the first completion provides a sufficiently specified treatment course for the stated question. Even then, the team must assess whether continuing assigned treatment is clinically meaningful and whether the data support estimating outcomes for those who discontinued. If discontinuation occurred because of intolerance, the scenario may be particularly dependent on extrapolation and should not be described as an outcome that was directly observed.

Checks, Comparisons, and Limitations

Before interpreting an analysis, check that its scenario matches the clinical question and that the reported result is a contrast for that scenario. A useful review should also examine how much of the result relies on estimating unobserved counterfactual outcomes.

  • Scenario ambiguity: If reasonable readers can imagine different treatment or care after the event, the scenario needs more detail.
  • Weak support in the data: If few participants with relevant histories follow a course resembling \(g\), the analysis may depend substantially on modeling assumptions.
  • Changing conclusions: Compare results under defensible alternative assumptions about outcomes after the event. Large changes indicate that the conclusion is sensitive to those assumptions, not that one scenario has automatically been proven correct.
  • Mismatch between label and analysis: An analysis restricted to observed event-free participants does not become a hypothetical estimand analysis simply because the report says “as if the event had not occurred.”

A treatment-policy estimand, introduced in the earlier material on Treatment-Policy Estimands, asks about outcomes regardless of whether the event occurs, so the event is retained as part of the treatment experience being summarized. A hypothetical estimand instead targets outcomes under a specified scenario that prevents the event. These are different clinical questions and can yield different answers. Choosing between them is not a technical preference: it depends on which treatment decision the result is intended to inform.

A hypothetical estimand also has limitations. The imagined scenario may be clinically unrealistic, ethically unacceptable to implement, or weakly supported by observed data. Even when it is clearly defined, its estimate can depend on unverifiable assumptions about outcomes that were not observed under that scenario. Reporting should therefore state the scenario, give the treatment contrast and its units, and make important assumptions and sensitivity to them visible. The result should not be interpreted as a direct description of what happened to participants who avoided the event.

Common pitfall: “The participants who did not use rescue medication are the participants who would have had no rescue medication, so their mean outcome estimates the hypothetical outcome.” This reasoning conditions on an observed post-randomization event and treats the resulting subset as if it represented the full target population under the scenario. Instead, define the counterfactual scenario explicitly and use an estimation approach whose assumptions address the outcomes not observed under it.

Check Your Understanding

Answer each question, then compare your reasoning with the solutions.

  1. A trial compares two treatments and asks for the mean week-16 outcome “if no participant started rescue medication.” Name two details that should be specified to make this a clearer hypothetical scenario.
  2. In a hypothetical analysis, the estimated mean outcome under the scenario is 12.4 units for treatment and 15.1 units for control. Calculate the treatment-minus-control contrast and interpret its sign.
  3. Why does comparing only participants who did not experience an intercurrent event generally not estimate a hypothetical estimand?
  4. Randomization was used, and the trial had no participants with a particular high-risk history who avoided the event. Why might an estimate for those participants under the no-event scenario be fragile?

Solutions. (1) Specify what treatment participants receive after the point when rescue would otherwise start, and what other care and follow-up apply; also state the target outcome and time point. (2) \(12.4-15.1=-2.7\) units. Under the specified scenario, the estimated treatment mean is 2.7 units lower than the control mean; whether lower is better depends on the outcome scale. (3) The observed event-free groups are selected after randomization and may differ in prognosis or treatment response. Their observed outcomes are not, in general, the full-population outcomes under the hypothetical scenario. (4) The data provide little or no direct support for the relevant history under the scenario. Estimation may rely strongly on extrapolation and modeling assumptions, which randomization alone does not verify.

Clinical Biostats